A carregar...
Pregnancy Outcomes in Men and Women Treated With Teriflunomide. A Population-Based Nationwide Danish Register Study
Background: The majority of persons diagnosed with multiple sclerosis (MS) experience their first MS symptoms in the reproductive age. Teriflunomide (TFL, Aubagio), was first released in Denmark for relapsing-remitting MS in December 2013. TFL treatment is contraindicated in women of childbearing po...
Na minha lista:
| Publicado no: | Front Immunol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6266987/ https://ncbi.nlm.nih.gov/pubmed/30532753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02706 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|